MannKind takes next step in rebuild with new FDA approval
IN THIS ARTICLE
- Latest news Topic
- Jorge Mercado Author
By Jorge Mercado Wednesday, May 25th, 2022
MannKind employees including CEO Michael Castagna, center, ring the opening bell of the Nasdaq on May 23. (courtesy photo) Five years ago, MannKind Corp. was in bad shape. With barely enough capital to fund its operations through August of 2017, a ton of debt and no real product pipeline, new CEO Michael Castagna, who took…